论文部分内容阅读
目的:探讨脑白质疏松(LA)对于脑梗死患者临床预后的影响。方法:脑梗死患者86例根据是否合并LA分为两组:伴LA为(LA+组,31例),不伴LA为(LA-组,55例),比较两组的临床预后。结果:LA+组的≥2个梗死灶率显著高于LA-组(38.71%vs5.45%),差异具有统计学意义(P<0.05);A+组的死亡率与LA-组无显著性差异(P>0.05),但LA+组再发脑卒中率显著高于LA-组(38.71%vs14.55%),差异具有统计学意义(P<0.05);治疗后6个月,LA+组的CCS评分显著高于LA-组,而MMSE及BI评分显著低于LA+组(P<0.05)。结论:脑梗死合并LA时将增加复发风险,且将明显影响临床预后。
Objective: To investigate the effect of leucopenia (LA) on the clinical prognosis of patients with cerebral infarction. Methods: Eighty-six patients with cerebral infarction were divided into two groups according to whether they were combined with LA or not: LA with LA (LA + group, 31 cases) and LA without LA (LA- group, 55 cases). The clinical outcomes were compared between the two groups. Results: ≥2 infarction rates in LA + group were significantly higher than those in LA-LA group (38.71% vs5.45%) (P <0.05). There was no significant difference between LA + group and LA- (P> 0.05). However, the recurrent stroke rate in LA + group was significantly higher than that in LA-LA group (38.71% vs14.55%, P <0.05) The score was significantly higher than that of LA-group, while MMSE and BI scores were significantly lower than those of LA + group (P <0.05). Conclusion: Cerebral infarction combined with LA will increase the risk of relapse, and will significantly affect the clinical prognosis.